The Canadian Rheumatology Association (CRA) has developed a formal GRADE recommendation for Covid-19 vaccination in persons with autoimmune rheumatic disease. The recommendation focuses on the use of the 2 currently approved COVID vaccines: BNT 162b2 (Pfizer-BioNTech) and mRNA-
As this is a ‘living guideline’, it will be updated on an ongoing basis as new evidence emerges. All are welcome to comment on this recommendation, including physicians, patients, caregivers, and members of the public. Click here to provide input.
This recommendation was developed as an adjunct to the recently updated CRA Position Statement on Covid-19 Vaccination, published January 21, 2021.